PCMA Launches Ad Campaign Targeting Independent Pharmacies
This article was originally published in The Pink Sheet Daily
Executive Summary
Print advertisements running in the Washington, D.C. area will stress that independent pharmacies are thriving and do not need special interest protections. The ad is drawn from a new PCMA study, which focuses on independent pharmacies and their legislative agenda.
You may also be interested in...
PCMA Will Appeal Court Decision Upholding Maine’s PBM Transparency Law
Bangor, Maine federal court adopts magistrate judge’s recommendation that preliminary injunction against Maine law be overturned. PCMA is seeking to block the law based on federal preemption under ERISA and a violation of the Takings Clause of the U.S. Constitution.
Endo’s Lidoderm Mailings Draw FDA Warning Letter For Unsubstantiated Claims
FDA asks Endo to disseminate “corrective messages” to doctors who received the violative promotional materials, which the agency says omit risk information and contain unsubstantiated effectiveness claims.
Efficacy Differences Within Drug Classes Unsupported By Data, FDA's Temple Says
Studies that look for differences in efficacy among members of the same drug class are only performed when necessary for approval, CDER Office of Medical Policy Director Temple tells DIA. While questioning the introduction of "follow-on" compounds, Temple also highlights AstraZeneca's success in achieving a more optimal dose for Nexium.